23 Feb ElevateBio
Kareem Reda, Chief Business Officer
Oct. 12 | 4:30pm | Oxford Biomedica Ballroom
ElevateBio is a technology-driven company built to power transformative cell and gene therapies today and for decades to come. The company has assembled industry-leading talent, built state-of-the-art facilities, and integrated diverse technology platforms, including gene editing, induced pluripotent stem cells, and protein, vector, and cellular engineering, necessary to drive innovation and commercialization of cellular and genetic medicines. At the center of the business model is BaseCamp, a purpose-built facility offering process development, analytics, automation, and current GMP manufacturing capabilities. Through BaseCamp and its enabling technologies, ElevateBio enables a wide range of partners from global biopharmaceuticals to early-stage biotechs to bring innovation from concept through commercialization while also developing its own portfolio of cell and gene therapies. Our team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.